About Clinical Research
The Clinical Research Division collaborates extensively with our colleagues throughout Fred Hutchinson Cancer Center as well as with our partner patient-care organizations — University of Washington Medical Center and Seattle Children’s. Additionally, we lead several nationwide multi-center studies aiming to improve cancer treatment and care. More than 75 percent of our faculty treat patients as well as conducting laboratory research and clinical trials.
To accelerate our research, division scientists can access critical shared institutional resources, including specimen storage, state-of-the-art imaging and structural analysis technology, pathology services, cell and reagent production, and clinical trials coordination and support.
Under the visionary leadership of internationally renowned breast oncology expert and leader in clinical and laboratory-based oncology research, Dr. Sara Hurvitz, we will work to boost the national reputation of the solid tumor clinical research program as well as oversee the continued growth of clinical research programs in stem cell transplantation and cell therapy, hematologic cancers and nonmalignant hematology.
Our Leadership
See our Faculty & Labs>
Director, Sara Hurvitz, M.D.
Dr. Sara Hurvitz is the Senior Vice President of the Clinical Research Division at Fred Hutch and Head of the newly united Division of Hematology and Oncology at the University of Washington Department of Medicine.
Hurvitz previously directed the Breast Oncology Program at UCLA and co-directed the Santa Monica-UCLA Outpatient Oncology Practice. She also served as the medical director of the Clinical Research Unit for UCLA’s Jonsson Comprehensive Cancer Center.
Utilizing her extensive experience in translational research — especially clinical trials — Hurvitz will concentrate on boosting the clinical cancer research pipeline, including funding, launch and enrollment for clinical trials.
Hurvitz' goal is to build on the current collaborations, accelerate research and improve care for our patients.
Associate Director, Stephanie Lee, M.D., M.P.H.
Dr. Stephanie Lee joined the Hutch in 2006 after completing a hematology/oncology fellowship at the Brigham and Women’s Hospital. In 2018, she earned an appointment as the Giuliani/Press Endowed Chair in Cancer Research.
Lee serves as Principal Investigator of the Chronic GVHD Consortium, an NIH-funded group that seeks to understand and cure chronic graft-versus-host disease, a serious complication of transplantation. In addition to her laboratory work, Lee treats patients with leukemia and other blood disorders at the Fred Hutch clinic.
A Legacy of Training
Past Leadership
E. Donnall Thomas, MD, 1974-1989
John Hansen, MD, 1989-1993
Fred Appelbaum, MD, 1993-2013
Oliver Press, MD, PhD, 2013-2016